Clotilde Allavena
Nantes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 118 publications
Drug interactions and kidney safety of bictegravir/emtricitabine/tenofovir alafenamide in kidney transplant recipients with HIV: an interventional pilot study.
Journal: The Journal of antimicrobial chemotherapy
Published: May 22, 2026
Long‑Term Effectiveness and Safety of Doravirine‑Based Antiretroviral Regimens in Virologically Suppressed People with HIV: The French Dat'AIDS Cohort.
Journal: Infectious diseases and therapy
Published: May 18, 2026
Lenacapavir Use in France: A National, Observational Study (LENAddOn).
Journal: Open forum infectious diseases
Published: April 23, 2026
Comparison of four frailty scores to predict adverse health events and mortality in people living with HIV aged 70 years and more (ANRS EP 66 SEPTAVIH study).
Journal: HIV medicine
Published: March 08, 2026
Archived M184V/I Mutation and Risk of Virological Failure After Switching to Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate: A National Observational Study (Dat'AIDS Cohort).
Journal: Open forum infectious diseases
Published: February 26, 2026
Virological failure and resistance emergence during treatment with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir/lamivudine in people living with HIV without prior resistance mutations: a real-world study.
Journal: The Journal of antimicrobial chemotherapy
Published: February 18, 2026
Short-cycle 4-days-per-week maintenance two-drug therapy in people living with HIV (ANRS-177 DUETTO): a randomised, open-label, multicentre, non-inferiority trial.
Journal: The lancet. HIV
Published: November 13, 2025
Calibration and discrimination ability of the Dat'AIDS score in people living with HIV aged 70 years and older from the Dat'AIDS cohort.
Journal: HIV medicine
Published: August 03, 2025
Switching from etravirine to doravirine in virologically suppressed people with HIV: results from the French multicentre SWEED observational study.
Journal: The Journal of antimicrobial chemotherapy
Published: June 22, 2025
Switch to bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV aged 65 years or older: BICOLDER study - IMEA 057.
Journal: Journal of infection and public health
Published: May 08, 2025
Kinetics of Non-nucleoside Reverse Transcriptase Inhibitor Resistance-associated Mutations in HIV-1 Proviral Cellular Reservoirs in Non-nucleoside Reverse Transcriptase Inhibitor-experienced Persons.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 10, 2025
Sex Differences in Patient-Reported Outcomes Among People Living With HIV Switching to an Oral Dual Therapy: Results From the PROBI Study.
Journal: AIDS research and treatment
Published: February 28, 2025
Last Updated: 09/26/2026